Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents
- 1 June 2014
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 80, 340-351
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Cucurbitacin E inhibits breast tumor metastasis by suppressing cell migration and invasionBreast Cancer Research and Treatment, 2012
- Synthetic Triterpenoids Target the Arp2/3 Complex and Inhibit Branched Actin PolymerizationJournal of Biological Chemistry, 2010
- Characterization of two classes of small molecule inhibitors of Arp2/3 complexNature, 2009
- Capping Protein Increases the Rate of Actin-Based Motility by Promoting Filament Nucleation by the Arp2/3 ComplexCell, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Single-Molecule Force Spectroscopy Study of Interaction between Transforming Growth Factor β1 and Its Receptor in Living CellsThe Journal of Physical Chemistry B, 2007
- The ARP2/3 complex: an actin nucleator comes of ageNature Reviews Molecular Cell Biology, 2006
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000
- 4-Thiazolidones. VI.1 The Preparation of Some 2-Substituted DerivativesJournal of the American Chemical Society, 1954
- 4-Thiazolidones. V. The Reaction of Some Semicarbazones with Thioglycolic AcidJournal of the American Chemical Society, 1952